Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000031153Phase 4Not yet recruiting
Phase 4, open-label, single-arm trial of sevoflurane and dexmedetomidine, sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: MOAA/S score and Aldrete score. Planned start Mar 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000031153.